Stock CMPS COMPASS PATHWAYS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Other languages COMPASS Pathways plc

Equities

CMPS

US20451W1018

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
7.94 USD +1.02% Intraday chart for COMPASS Pathways plc -5.25% -9.26%
04-18 Compass Pathways Insider Sold Shares Worth $597,964, According to a Recent SEC Filing MT
04-18 Compass Pathways Insider Sold Shares Worth $597,964, According to a Recent SEC Filing MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Compass Pathways Insider Sold Shares Worth $597,964, According to a Recent SEC Filing
Compass Pathways Insider Sold Shares Worth $597,964, According to a Recent SEC Filing
Compass Pathways Insider Sold Shares Worth $461,332, According to a Recent SEC Filing
Compass Pathways Insider Sold Shares Worth $461,332, According to a Recent SEC Filing
Compass Pathways Insider Sold Shares Worth $445,552, According to a Recent SEC Filing
Compass Pathways Insider Sold Shares Worth $445,552, According to a Recent SEC Filing
Compass Pathways Co-Founders Step Down From Board; David Norton Named Interim Chair; Shares Fall
COMPASS Pathways plc Announces Board Changes
Compass Pathways Insider Sold Shares Worth $704,821, According to a Recent SEC Filing
Compass Pathways Insider Sold Shares Worth $704,821, According to a Recent SEC Filing
COMPASS Pathways plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
COMPASS Pathways plc Reports Earnings Results for the Full Year Ended December 31, 2023
Compass Pathways Insider Sold Shares Worth $609,862, According to a Recent SEC Filing
Compass Pathways Insider Sold Shares Worth $609,862, According to a Recent SEC Filing
Compass Pathways Insider Sold Shares Worth $902,124, According to a Recent SEC Filing
Compass Pathways Insider Sold Shares Worth $902,124, According to a Recent SEC Filing
Compass Pathways Insider Sold Shares Worth $752,954, According to a Recent SEC Filing
Compass Pathways Insider Sold Shares Worth $752,954, According to a Recent SEC Filing
Compass Pathways plc Enters into Research Collaboration Agreement with Hackensack Meridian Health to Develop Optimal Clinical Model for Investigational Comp360 Psilocybin Treatment, If FDA-Approved
Compass Pathways, Greenbrook TMS Start Research Collaboration on Psilocybin Treatment
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CMPS Stock
  4. News COMPASS Pathways plc
  5. Other languages